Hydroxypropylmethylcellulose films for the ophthalmic delivery of diclofenac sodium

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 2, 2013, Pages 193-200

  El Sousi, Salah ^a   Nácher, Amparo ^b   Mura, Carla ^b   Catalán Latorre, Ana ^b   Merino, Virginia ^b   Merino Sanjuán, Matilde ^b   Díez Sales, Octavio ^b  

^a AL AZHAR UNIVERSITY   (Palestine)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

corneal permeation studies; diclofenac sodium; HPMC films; nanoparticles; release studies

Indexed keywords

DICLOFENAC; HYDROXYPROPYLMETHYLCELLULOSE; NANOPARTICLE;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; ENCAPSULATION; FEMALE; GELATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; LIGHT SCATTERING; NONHUMAN; PARTICLE SIZE; PHASE TRANSITION; PHYSICAL CHEMISTRY; PRECIPITATION; SHEAR STRESS; STEADY STATE; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; VISCOSITY; ZETA POTENTIAL;

ADMINISTRATION, OPHTHALMIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHITOSAN; DICLOFENAC; DOSAGE FORMS; DRUG DELIVERY SYSTEMS; HYALURONIC ACID; METHYLCELLULOSE; NANOPARTICLES; PERMEABILITY; POLYMERS;

EID: 84871713180     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2012.01587.x     Document Type: Article

References (32)

1. Ding S,. Recent developments in ophthalmic drug delivery. Pharm Sci Technolo Today 1998; 1: 328-335.
2. Cao F, et al,. Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery. Int J Pharm 2011; 404: 250-256.
3. Karatas A, Bakara T,. Studies on indomethacin films prepared by water-soluble polymers. II. The relation between dissolution rate and swelling behaviour. Farmaco 2001; 56: 197-202.
4. Siepmann J, Peppas NA,. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001; 48: 139-157.
5. Toda I, et al,. Hydroxypropyl methylcellulose for the treatment of severe dry eye associated with Sjögren's syndrome. Cornea 1996; 15: 120-128.
6. Ludwing A,. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005; 57: 1595-1639.
7. Liu CH, et al,. In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets. J Pharm Pharmacol 1995; 47: 360-364.
8. Zimmer A, Kreuter J,. Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev 1995; 16: 61-73.
9. Kaur IP, et al,. Vesicular systems in ocular drug delivery: an overview. Int J Pharm 2004; 269: 1-14.
10. Ludwig A,. The use of mucoadhesive polymers in ocular drug delivery. Adv Drug Deliv Rev 2005; 57: 1595-1639.
11. Alonso MJ, Sanchez A,. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol 2003; 55: 1451-1463.
12. Diabold Y, et al,. Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP). Biomaterials 2007; 28: 1553-1564.
13. Durrani AM, et al,. Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye. Int J Pharm 1995; 118: 243-250.
14. Ahuja M, et al,. Topical ocular delivery of NSAIDs. AAPS J 2008; 10: 229-241.
15. Li N, et al,. Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery. Int J Pharm 2009; 379: 131-138.
16. Manconi M, et al,. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction. Eur J Pharm Biopharm 2011; 78: 27-35.
17. Agnihotri SM, Vavia PR,. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine 2009; 5: 90-95.
18. Valls R, et al,. Transcorneal permeation in a corneal device of non-steroidal anti-inflammatory drugs in drug delivery systems. Open Med Chem J 2008; 22: 66-71.
19. De la Fuente M, et al,. Bioadhesive hyaluronan-chitosan nanoparticles can transport genes across the ocular mucosa and transfect ocular tissue. Gene Ther 2008; 15: 668-676.
20. De la Fuente M, et al,. Novel hyaluronan-based nanocarriers for transmucosal delivery of macromolecules. Macromol Biosci 2008; 8: 441-450.
21. Riegel M, Ellis PP,. High-performance liquid chromatographic assay for antiinflammatory agents diclofenac and flurbiprofen in ocular fluids. J Chromatogr B Biomed Appl 1994; 654: 140-145.
22. Sittikijyothin W, et al,. Modelling the rheological behavior of galactomannan aqueous solutions. Carbohydr Polym 2005; 59: 339-350.
23. Ritger PL, Peppas NA,. A simple equation for description of solute release. II. Fickian and anomalous release from swellable devices. J Control Release 1987; 5: 37-42.
24. Seipmann J, Peppas NA,. Modeling of drug release from delivery systems based on methylcellulose (HPMC). Adv Drug Deliv Rev 2001; 48: 139-157.
25. Li X, et al,. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm 2008; 363: 177-182.
26. Luo Q, et al,. Nanostructured lipid carrier (NLC) coated with chitosan oligosaccharides and its potential use in ocular drug delivery system. Int J Pharm 2011; 403: 185-191.
27. Monti D, et al,. Increased corneal hydration induced by potential ocular penetration enhancers: assessment by differential scanning calorimetry (DSC) and by desiccation. Int J Pharm 2002; 232: 139-147.
28. Calvo P, et al,. Novel hydrophilic chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl Polym Sci 1997; 63: 125-132.
29. Oyarzun-Ampuero FA, et al,. Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma. Int J Pharm 2009; 381: 122-129.
30. Dolz M, et al,. Oscillatory measurements for salad dressings stabilized with modified starch, xanthan gum, and locust bean gum. J Appl Pol Sci 2006; 102: 897-903.
31. Chattarj SC, et al,. A simple diffusion cell to monitor drug release from semi-solid dosage forms. Int J Pharm 1995; 120: 119-124.
32. Bonina FP, et al,. Adsorption of salicylic acid on bentonite and kaolin and release experiments. Appl Clay Sci 2007; 36: 77-85.